VEUAX Mutual Fund

NAV$44.66

Fund Essentials - as of Jan 31, 2026

Net Assets
$123M
Expense Ratio
1.00%
Dividend Yield (Current)
3.20%
Holdings
84
Inception Date
Nov 2, 1995
Fund Family
J.P. Morgan Asset Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+6.38%
1 Year+16.54%
3 Year+18.30%
5 Year+10.24%
10 Year+9.88%

Asset Allocation

Stocks: 98.16%
Cash: 1.83%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASAsml Holding Nv5.03%
NOVN:SMNovartis Ag Ordinary Shares3.03%
SAN:MABanco Santander S.a.2.95%
SHEL:LNShell Plc ADR2.47%
BARC:LNBarclays Plc2.22%
Top 10 Concentration: 26.12%Report Date: Jan 31, 2026
Download all 84 holdings for VEUAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.20%
Frequency
Annually
Latest Distribution
$0.62
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how VEUAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

VEUAX Mutual Fund Overview

VEUAX Mutual Fund (JPMorgan Europe Dynamic Fund Class A) is managed by J.P. Morgan Asset Management with $123.2M in net assets. VEUAX expense ratio is 1.00%, holding 84 positions across sectors including Unknown, Financials, Health Care. Inception date: 1995-11-02.

VEUAX performance shows a YTD return of 6.38%. The 1-year return is 16.54% and the 5-year return is 10.24%. VEUAX dividend yield stands at 3.20%, paid annually.

VEUAX top holdings include Asml Holding Nv (5.0%), Novartis Ag Ordinary Shares (3.0%), Banco Santander S.a. (3.0%), Shell Plc ADR (2.5%), Barclays Plc (2.2%). View all VEUAX holdings, sector breakdown, or dividend history.

VEUAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VEUAX alternatives are available via the screener, along with tax-loss harvesting opportunities.